Praxis Precision Medicines (PRAX) Research & Development (2019 - 2026)

Praxis Precision Medicines' Research & Development history runs 8 years deep, the most recent figure standing at $78.0 million for Q1 2026.

• In Q1 2026, Research & Development rose 28.26% year-over-year to $78.0 million; the TTM figure through Mar 2026 stood at $284.3 million (up 52.65% YoY), while the FY2025 annual figure was $267.1 million, up 75.26% from the prior year.
• Research & Development was $78.0 million for Q1 2026 at Praxis Precision Medicines, up from $77.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $78.0 million in Q1 2026 to a low of $17.3 million in Q3 2023.
• Historically, Research & Development has averaged $43.5 million across 5 years, with a median of $41.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Research & Development plunged 51.56% in 2023, then jumped 206.11% in 2024.
• A 5-year view of Research & Development shows it stood at $28.3 million in 2022, then sank by 35.09% to $18.4 million in 2023, then surged by 206.11% to $56.3 million in 2024, then surged by 37.7% to $77.5 million in 2025, then grew by 0.62% to $78.0 million in 2026.
• The last three Research & Development figures came in at $78.0 million (Q1 2026), $77.5 million (Q4 2025), and $65.8 million (Q3 2025), per Business Quant data.